SCHEMBL2344654

SCHEMBL2344654

CC(=O)C(C)CC(C)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAALAD2 Q9Y3Q0 3/20 0.48
FOLH1 Q04609 2/20 0.48
ENPEP Q07075 2/20 0.48
GABRR1 P24046 2/20 0.44
CYP1A2 P05177 1/20 0.44
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
RNPEP Q9H4A4 1/20 0.39
SLC7A5 Q01650 1/20 0.39
TP53 P04637 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12951360 1.00 NAALAD2 (0.48) NAALAD2FOLH1ENPEPGABRR1CYP1A2
SCHEMBL443229 0.88 NAALAD2 (0.56) NAALAD2FOLH1ENPEPGABRR1CYP1A2
SCHEMBL10938417 0.88 NAALAD2 (0.56) NAALAD2FOLH1ENPEPGABRR1CYP1A2
SCHEMBL17953984 0.88 ALDH1A1 (0.40) NAALAD2FOLH1ENPEPCYP1A2RNPEP
SCHEMBL12891365 0.88 ALDH1A1 (0.40) NAALAD2FOLH1ENPEPCYP1A2RNPEP
SCHEMBL7314519 0.88 NAALAD2 (0.56) NAALAD2FOLH1ENPEPGABRR1CYP1A2
SCHEMBL8971305 0.81 FOLH1 (0.46) NAALAD2FOLH1ENPEPGABRR1CYP1A2
SCHEMBL9638884 0.81 NAALAD2 (0.46) NAALAD2FOLH1ENPEPGABRR1CYP1A2
SCHEMBL23468436 0.80 FOLH1 (0.57) NAALAD2FOLH1ENPEPGABRR1CYP1A2
SCHEMBL2348277 0.80 GABRR1 (0.59) NAALAD2FOLH1ENPEPGABRR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240140888-A1 COMPOSITION COMPRISING AN ALKANE AND AN OXOESTER BIOSYNTHIS (FR) 2024-05-02 US disclosed
WO-2015035412-A1 CATALYST-CONTROLLED ALIPHATIC C-H OXIDATIONS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2015-03-12 WO disclosed
EP-1544190-B1 METHOD FOR PRODUCING CARBOXYLIC ACIDS NAT INST OF ADVANCED IND SCIEN (JP) 2011-08-31 EP disclosed
CN-101100429-B Process for producing carbonyl or hydroxy compound SUMITOMO CHEMICAL CO 2011-01-19 CN disclosed
CN-100402474-C Process for producing carbonyl or hydroxy compound SUMITOMO CHEMICAL CO (JP) 2008-07-16 CN disclosed
CN-101100429-A Process for producing carbonyl or hydroxy compound SUMITOMO CHEMICAL COMPANY LIMT (JP) 2008-01-09 CN disclosed
CN-1313428-C Method for producing carboxylic acid NAT INST OF ADVANCED IND SCIEN (JP) 2007-05-02 CN disclosed
US-7186858-B2 Method for producing carboxylic acid NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2007-03-06 US disclosed
US-20050215817-A1 Method for producing carboxylic acid NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2005-09-29 US disclosed
CN-1671642-A Process for producing carboxylic acid NAT INST OF ADV IND & TECHNOL (JP) 2005-09-21 CN disclosed
EP-1188735-B1 Process for producing carbonyl or hydroxy compound SUMITOMO CHEMICAL CO (JP) 2005-07-27 EP disclosed
EP-1544190-A1 METHOD FOR PRODUCING CARBOXYLIC ACID National Institute of Advanced Industrial Science and Technology (JP) 2005-06-22 EP disclosed
US-20040152592-A1 Process for producing carbonyl or hydroxy compound SUMITOMO CHEMICAL COMPANY, LIMTED 2004-08-05 US disclosed
US-6703528-B2 CATALYTIC OXIDATION OF OLEFIN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-03-09 US disclosed
CN-1347861-A Process for producing carbonyl or hydroxy compound SUMITOMO CHEMICAL CO (JP) 2002-05-08 CN disclosed
EP-1188735-A1 Process for producing carbonyl or hydroxy compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-03-20 EP disclosed
US-20020025906-A1 Process for producing carbonyl or hydroxy compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-02-28 US disclosed
US-4072660-A FROM A 4-OXO-CARBOXYLIC ACID ESTER OR DELTA-ENOL-LACTONE AND STRONG BASE IN GLYCOL DIALKYL ETHER SOLVENT HOECHST AKTIENGESELLSCHAFT (DT) 1978-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240140888-A1 COMPOSITION COMPRISING AN ALKANE AND AN OXOESTER ALKBH2, ABHD12, FAAH2 NAALAD2 1455/4885FOLH1 3810/4885ENPEP 4177/4885
US-20050215817-A1 Method for producing carboxylic acid ADH1C, HAO2, ALDH2 NAALAD2 1798/4885FOLH1 1534/4885ENPEP 2227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.